Pharmaceutical Industry in Qatar by Al-Mohannadi, Ahmed
PHARMACEUTICAL INDUSTRY IN QATAR 
DR. AHMED AL-MOHANNADI 
CEO, Q LIFE PHARMA 
1 
  
Presenting Authors Have No Relationships  
to Disclose 
 
 
Disclosure of Conflict of 
Interest 
Dr. Ahmed Al Mohannadi 
10th Mar 2018 
       “Medication Sector in Qatar”  
       After Math  
Hand in Hand Facing the Embargo 
                             
MANY THANKS TO HIS HIGHNESS EMIR OF QATAR  4 
       
 Current Pharma Market Share of Qatar 
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OVERVIEW: 
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Estimated Current Market Share 
GCC - 1% of world pharma business (13 billion USD) 
 Qatar shows approximately 600 million USD 
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• Imported Brands & Generic medicines from 
the GCC & around the world 
BEFORE 
• Stopped importing Generics from KSA, 
UAE, Bahrain and Egypt  
• Started Importing Generics and Brands 
from around the world at a higher price  
AFTER 
Medicine Availability Before and 
After Blockade 
Consequences of depending on 
importing from other countries 
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1 
•Sudden discontinuation from supplying 
countries 
2 
•Big shortage of trusted medicines 
3 
•High cost of purchases 
4 
•No self-sufficiency in Medicines 
5 
•No well-established R&D in the country 
Advantages of producing locally 
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1 
•No effect by discontinuation of supplying 
countries. 
2 
•No shortage of essential medicines 
3 
•High cost of purchase can be controlled 
4 
•Self sufficiency in Medicines. 
5 
•Country owned R&D 
6 
•New job creation 
7 
•Export Business 
8 
•Assurance of quality 
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o Technology and knowledge transfer  
o Small market for Generic medicines  
o Very high over heads 
o Scarcity of Qatari Human recourses in the 
Pharmaceutical industry   
o Lack of raw materials 
o Complicated rules and regulations 
o Delayed documentation  
o Qatar is not one of the reference countries in 
medicine 
Main Challenges and Barriers of 
Local Manufacturer  
 Establishing new rules and regulations to counter the 
new situation  
 Prioritizing Qatari products  
 Registration control on similar generic products that are 
already produced in Qatar 
 Enforcing a law to encourage international innovator 
manufactures to corporate with local manufacturers 
(Under license)  
 Fast track approval for all pharmaceutical files 
 Encourage pharmaceutical engineering course by 
universities in Qatar 
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Recommended steps to overcome the 
challenges and barriers 
PROMOTE THE PRODUCTION OF  
PHARMACEUTICALS & GENERICS 
WITH THE HELP OF 
LOCALLY REGISTERED COMPANIES 
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CONCLUSION: 
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